刑事司法系统推荐的阿片类药物使用障碍治疗中药物使用的差异。

IF 9.5 Q1 HEALTH CARE SCIENCES & SERVICES
J Travis Donahoe, Julie M Donohue, Brendan K Saloner
{"title":"刑事司法系统推荐的阿片类药物使用障碍治疗中药物使用的差异。","authors":"J Travis Donahoe, Julie M Donohue, Brendan K Saloner","doi":"10.1001/jamahealthforum.2024.2807","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Individuals with opioid use disorder (OUD) and criminal justice system involvement experience high rates of overdose death. Historical data point to limited use of medications for opioid use disorder (MOUD) in criminal justice system-referred treatment for OUD as playing a role. However, how MOUD use among those referred to treatment by the criminal justice system has changed relative to other referral sources over time is still unclear, as well as how it varies across states.</p><p><strong>Objective: </strong>To examine disparities in the use of MOUD between individuals referred to treatment by the criminal justice system compared to other referral sources over time.</p><p><strong>Design, setting, and participants: </strong>This cross-sectional study included admissions to specialty substance use treatment facilities for OUD in the national Treatment Episodes Dataset-Admissions from 2014 to 2021. Logistic regression models were used to examine trends in the probability of MOUD use among individuals with and without criminal justice referrals for OUD treatment, as well as any differential trends by state. The data were analyzed from September 2023 to August 2024.</p><p><strong>Main outcome and measure: </strong>The main outcome was the probability that treatment for individuals with OUD included MOUD.</p><p><strong>Results: </strong>A total of 3 235 445 admissions were analyzed in the study data. Among individuals referred to OUD treatment by the criminal justice system, the probability that treatment included MOUD increased by 3.42 percentage points (pp) (95% CI, 3.37 pp to 3.47 pp) annually from 2014 to 2021. This was faster than the increase in the probability of MOUD use for noncriminal justice-referred admissions (2.49 pp [95% CI, 2.46 pp to 2.51 pp) and reduced, but did not eliminate, disparities in MOUD use between individuals with and without criminal justice system-referred treatment. In 2021, only 33.6% of individuals in criminal justice system-referred treatment received MOUD, 15.6 pp lower than for individuals referred to treatment by other sources. Trends in the probability of MOUD use varied substantially for individuals in criminal justice system-referred treatment across states, but very few experienced enough growth to eliminate this disparity.</p><p><strong>Conclusions and relevance: </strong>The results of this cross-sectional study suggest that targeted efforts to address persistent disparities in MOUD use among those with OUD and criminal justice system involvement are needed to address the poor health outcomes experienced by this population.</p>","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"5 9","pages":"e242807"},"PeriodicalIF":9.5000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380100/pdf/","citationCount":"0","resultStr":"{\"title\":\"Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment.\",\"authors\":\"J Travis Donahoe, Julie M Donohue, Brendan K Saloner\",\"doi\":\"10.1001/jamahealthforum.2024.2807\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Importance: </strong>Individuals with opioid use disorder (OUD) and criminal justice system involvement experience high rates of overdose death. Historical data point to limited use of medications for opioid use disorder (MOUD) in criminal justice system-referred treatment for OUD as playing a role. However, how MOUD use among those referred to treatment by the criminal justice system has changed relative to other referral sources over time is still unclear, as well as how it varies across states.</p><p><strong>Objective: </strong>To examine disparities in the use of MOUD between individuals referred to treatment by the criminal justice system compared to other referral sources over time.</p><p><strong>Design, setting, and participants: </strong>This cross-sectional study included admissions to specialty substance use treatment facilities for OUD in the national Treatment Episodes Dataset-Admissions from 2014 to 2021. Logistic regression models were used to examine trends in the probability of MOUD use among individuals with and without criminal justice referrals for OUD treatment, as well as any differential trends by state. The data were analyzed from September 2023 to August 2024.</p><p><strong>Main outcome and measure: </strong>The main outcome was the probability that treatment for individuals with OUD included MOUD.</p><p><strong>Results: </strong>A total of 3 235 445 admissions were analyzed in the study data. Among individuals referred to OUD treatment by the criminal justice system, the probability that treatment included MOUD increased by 3.42 percentage points (pp) (95% CI, 3.37 pp to 3.47 pp) annually from 2014 to 2021. This was faster than the increase in the probability of MOUD use for noncriminal justice-referred admissions (2.49 pp [95% CI, 2.46 pp to 2.51 pp) and reduced, but did not eliminate, disparities in MOUD use between individuals with and without criminal justice system-referred treatment. In 2021, only 33.6% of individuals in criminal justice system-referred treatment received MOUD, 15.6 pp lower than for individuals referred to treatment by other sources. Trends in the probability of MOUD use varied substantially for individuals in criminal justice system-referred treatment across states, but very few experienced enough growth to eliminate this disparity.</p><p><strong>Conclusions and relevance: </strong>The results of this cross-sectional study suggest that targeted efforts to address persistent disparities in MOUD use among those with OUD and criminal justice system involvement are needed to address the poor health outcomes experienced by this population.</p>\",\"PeriodicalId\":53180,\"journal\":{\"name\":\"JAMA Health Forum\",\"volume\":\"5 9\",\"pages\":\"e242807\"},\"PeriodicalIF\":9.5000,\"publicationDate\":\"2024-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380100/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA Health Forum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/jamahealthforum.2024.2807\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA Health Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jamahealthforum.2024.2807","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

重要性:患有阿片类药物使用障碍 (OUD) 并卷入刑事司法系统的患者因用药过量而死亡的比例很高。历史数据表明,在刑事司法系统推荐的 OUD 治疗中,阿片类药物使用障碍 (MOUD) 药物使用有限,这也是其中的一个原因。然而,与其他转介来源相比,刑事司法系统转介治疗者使用阿片类药物的情况随着时间的推移发生了怎样的变化,以及各州之间的差异如何,目前仍不清楚:目的:研究随着时间的推移,刑事司法系统转介的治疗对象与其他转介来源的治疗对象在使用MOUD方面的差异:这项横断面研究包括 2014 年至 2021 年期间全国治疗事件数据集(Treatment Episodes Dataset-Admissions)中因 OUD 而被专业药物使用治疗机构收治的患者。研究使用逻辑回归模型来检验有刑事司法转介和没有刑事司法转介接受 OUD 治疗的人使用 MOUD 的概率趋势,以及各州的不同趋势。数据分析时间为 2023 年 9 月至 2024 年 8 月。主要结果和衡量标准:主要结果是对 OUD 患者的治疗包括 MOUD 的概率:研究数据共分析了 3 235 445 例入院患者。在由刑事司法系统转介接受 OUD 治疗的患者中,从 2014 年到 2021 年,治疗包含 MOUD 的概率每年增加 3.42 个百分点(95% CI,3.37 个百分点至 3.47 个百分点)。这比非刑事司法转介入院患者使用 MOUD 的概率增长(2.49 个百分点[95% CI,2.46 个百分点至 2.51 个百分点])更快,并且缩小了但并未消除接受刑事司法系统转介治疗和未接受刑事司法系统转介治疗的患者之间使用 MOUD 的差距。2021 年,在接受刑事司法系统转介治疗的患者中,只有 33.6% 的人接受了 MOUD 治疗,比通过其他渠道转介治疗的患者低 15.6 个百分点。各州接受刑事司法系统转介治疗的个人使用 MOUD 的概率趋势差异很大,但只有极少数州经历了足以消除这种差异的增长:这项横断面研究的结果表明,有必要采取有针对性的措施,解决那些患有 OUD 并涉及刑事司法系统的人在使用 MOUD 方面持续存在的差异,以解决这一人群健康状况不佳的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment.

Importance: Individuals with opioid use disorder (OUD) and criminal justice system involvement experience high rates of overdose death. Historical data point to limited use of medications for opioid use disorder (MOUD) in criminal justice system-referred treatment for OUD as playing a role. However, how MOUD use among those referred to treatment by the criminal justice system has changed relative to other referral sources over time is still unclear, as well as how it varies across states.

Objective: To examine disparities in the use of MOUD between individuals referred to treatment by the criminal justice system compared to other referral sources over time.

Design, setting, and participants: This cross-sectional study included admissions to specialty substance use treatment facilities for OUD in the national Treatment Episodes Dataset-Admissions from 2014 to 2021. Logistic regression models were used to examine trends in the probability of MOUD use among individuals with and without criminal justice referrals for OUD treatment, as well as any differential trends by state. The data were analyzed from September 2023 to August 2024.

Main outcome and measure: The main outcome was the probability that treatment for individuals with OUD included MOUD.

Results: A total of 3 235 445 admissions were analyzed in the study data. Among individuals referred to OUD treatment by the criminal justice system, the probability that treatment included MOUD increased by 3.42 percentage points (pp) (95% CI, 3.37 pp to 3.47 pp) annually from 2014 to 2021. This was faster than the increase in the probability of MOUD use for noncriminal justice-referred admissions (2.49 pp [95% CI, 2.46 pp to 2.51 pp) and reduced, but did not eliminate, disparities in MOUD use between individuals with and without criminal justice system-referred treatment. In 2021, only 33.6% of individuals in criminal justice system-referred treatment received MOUD, 15.6 pp lower than for individuals referred to treatment by other sources. Trends in the probability of MOUD use varied substantially for individuals in criminal justice system-referred treatment across states, but very few experienced enough growth to eliminate this disparity.

Conclusions and relevance: The results of this cross-sectional study suggest that targeted efforts to address persistent disparities in MOUD use among those with OUD and criminal justice system involvement are needed to address the poor health outcomes experienced by this population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.00
自引率
7.80%
发文量
0
期刊介绍: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health, and health care. The journal publishes original research, evidence-based reports, and opinion about national and global health policy. It covers innovative approaches to health care delivery and health care economics, access, quality, safety, equity, and reform. In addition to publishing articles, JAMA Health Forum also features commentary from health policy leaders on the JAMA Forum. It covers news briefs on major reports released by government agencies, foundations, health policy think tanks, and other policy-focused organizations. JAMA Health Forum is a member of the JAMA Network, which is a consortium of peer-reviewed, general medical and specialty publications. The journal presents curated health policy content from across the JAMA Network, including journals such as JAMA and JAMA Internal Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信